海南海藥(000566.SZ)收到海南證監局警示函
格隆匯3月4日丨海南海藥(000566.SZ)公佈,公司於2020年3月4日收到中國證券監督管理委員會海南監管局《關於對海南海藥股份有限公司採取出具警示函措施的決定》。
2020年2月14日,公司披露《關於抗病毒藥物研製取得進展的公告》中關於抗病毒藥物的生產情況表述不準確,且未作出有針對性的風險提示,未能客觀、真實、準確地介紹和反映抗病毒藥物的實際生產情況。
上述行為違反了《上市公司信息披露管理辦法》(證監會令第40號)第二條的規定。根據《上市公司信息披露管理辦法》第五十九條的規定,海南證監局決定對公司採取出具警示函的監管措施,要求公司嚴格遵守《證券法》等法律法規,認真履行信息披露義務,杜絕類似行為再次發生,確保公司真實、準確、完整、及時、公平地履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.